AstraZeneca's COVID-19 vaccine, Vaxzevria (ChAdOx1-S [Recombinant]), has been granted approval in the European Union (EU) by the European Medicine Agency (EMA) as a third dose booster in adults. Healthcare professionals can now use Vaxzevria as a third dose booster in patients previously given a primary vaccine .
Ever since COVID-19 vaccines were introduced in late 2020, vaccine resistance has remained a common phenomenon. Lower willingness to get the COVID-19 vaccine has been associated with exposure to online misinformation. This column investigates the role of cable news on vaccine scepticism and vaccination rates in the US. It finds that exposure to Fox News reduces COVID-19